Skip to content

Hyperbaric Oxygen in Patients Who Had a Stroke

Hyperbaric Oxygen Treatment in Chronic Stroke a Feasibility Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04297358
Acronym
HOST
Enrollment
10
Registered
2020-03-05
Start date
2017-12-20
Completion date
2022-12-31
Last updated
2023-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperbaric Oxygen, Stroke

Keywords

Hyperbaric Oxygen, Completed Stroke, Feasibility, Prospective

Brief summary

Prospective clinical assessment of 40 Hyperbaric Oxygen (HBO) treatments in 10 completed stroke patients.

Detailed description

10 patients having suffered a stroke and having being rehabilitated will be treated with 40 consecutive Hyperbaric Oxygen Treatment (HBOT) after a minimal delay of 3 months after stroke. They will be neurologically assessed before and 3 months after HBOT. Rivermead mobility index will be also assessed.

Interventions

DRUGHyperbaric oxygen

40 consecutive (5/7) sessions of hyperbaric oxygen

Sponsors

Hyperbaric Center Basel
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with ischemic cortical stroke in chronic stage (≥ 3 months) with residual motor deficits confirmed by imaging with brain CT scan and/or brain MRI Informed consent

Exclusion criteria

* Neurological issue: * inability to understand the informed consent form * Hemiplegia * Hyperbaric issue: * Claustrophobia * inability to put on face mask * uncontrolled epilepsy * dementia or psychological disturbance * previous pneumothorax * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in Rivermead mobility index (RMI) at 3 monthsChange from Baseline RMI at 3 monthsMobility scale used in neurological rehabilitation. All items are rated in a yes/no format with positive responses scoring a 1 for a maximal RMI score of 15 (15 is better). Changes are evaluated every two weeks for a total of 8 weeks (every 10 sessions of HBOT), than after 1 and 3 months.
Change in Rivermead mobility index (RMI) at 8 weeksChange from Baseline RMI at 8 weeksMobility scale used in neurological rehabilitation. All items are rated in a yes/no format with positive responses scoring a 1 for a maximal RMI score of 15 (15 is better). Changes are evaluated every two weeks for a total of 8 weeks (every 10 sessions of HBOT), than after 1 and 3 months.
Change in Rivermead mobility index (RMI) at 1 monthChange from Baseline RMI at 1 monthMobility scale used in neurological rehabilitation. All items are rated in a yes/no format with positive responses scoring a 1 for a maximal RMI score of 15 (15 is better). Changes are evaluated every two weeks for a total of 8 weeks (every 10 sessions of HBOT), than after 1 and 3 months.
Change in National Institutes of Health Stroke Scale (NIHSS score)Change from Baseline NIHSS Score at 3 monthsNeurological assessment before and after HBOT. Composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment. The individual scores from each item are summed in order to calculate a patient's total NIHSS score. The maximum possible score is 42, with the minimum score being a 0 (0 is better).
Change in Rivermead mobility index (RMI) at 2 weeksChange from Baseline RMI at 2 weeksMobility scale used in neurological rehabilitation. All items are rated in a yes/no format with positive responses scoring a 1 for a maximal RMI score of 15 (15 is better). Changes are evaluated every two weeks for a total of 8 weeks (every 10 sessions of HBOT), than after 1 and 3 months.
Change in Rivermead mobility index (RMI) at 4 weeksChange from Baseline RMI at 4 weeksMobility scale used in neurological rehabilitation. All items are rated in a yes/no format with positive responses scoring a 1 for a maximal RMI score of 15 (15 is better). Changes are evaluated every two weeks for a total of 8 weeks (every 10 sessions of HBOT), than after 1 and 3 months.
Change in Rivermead mobility index (RMI) at 6 weeksChange from Baseline RMI at 6 weeksMobility scale used in neurological rehabilitation. All items are rated in a yes/no format with positive responses scoring a 1 for a maximal RMI score of 15 (15 is better). Changes are evaluated every two weeks for a total of 8 weeks (every 10 sessions of HBOT), than after 1 and 3 months.

Secondary

MeasureTime frameDescription
Change in Visual AcuityChange from Baseline Visual Acuity at 3 monthsSnellen chart. Visual acuity test from a distance of 6m. 1 is normal vision, 0 is blindness. Each eye is assessed.
Tympanic damageFrom date of Start of HBOT until the date of End of HBOTDigital photography before and after each daily HBOT session, that means before and after each compression/decompression in the hyperbaric chamber, to detect any ear lesion.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026